Cromolyn (EENT)

Drug class: Antineoplastic Agents

Usage of Cromolyn (EENT)

Allergic Rhinitis

Self-medication for the symptomatic prevention and treatment of seasonal or perennial allergic rhinitis. Provides symptomatic relief of rhinorrhea, nasal congestion, sneezing, and postnasal drip.

Should not use as self-medication for the treatment of sinus infection† [off-label], asthma† [off-label], or cold symptoms† [off-label].

Allergic Ocular Disorders

Symptomatic treatment of certain allergic ocular disorders (e.g., vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis).

Has been used for the treatment of giant papillary conjunctivitis† [off-label].

Relate drugs

How to use Cromolyn (EENT)

General

  • For patients with seasonal or perennial rhinitis, continue therapy throughout the period of allergen exposure (e.g., until the pollen season is over or contact with allergen has ceased).
  • If exposure to allergens cannot be predicted, initiate therapy at the first sign of nasal symptoms.
  • Should not use other ocular agents with ophthalmic solution unless directed by a clinician. However, may use corticosteroids with ophthalmic solution.

    • Administration

    Administer intranasally or topically to the eye.

    Administer at regular intervals.

    Intranasal Administration

    Parents or care providers must supervise use by young children. In very young children, an adult should administer nasal solution. Use care when inserting the nozzle into the nose to avoid injury.

    Prior to administration, clear nasal passages by blowing the nose; administration of a topical nasal decongestant may be necessary. Inhale through the nose during administration.

    For maximum therapeutic effect, initiate therapy before (e.g., ≤1–2 weeks before) and continue at regular intervals during the period of allergen exposure.

    Ophthalmic Administration

    Applied topically to the eye as an ophthalmic solution just inside the lower eyelid; patients should avoid applying the solution directly on the cornea.

    To avoid contamination of dropper tip and solution, avoid touching the tip of the dispensing dropper or container to the eye, fingers, or any other surface.

    Dosage

    Available as cromolyn sodium.

    Nasal pump delivers 5.2 mg of cromolyn sodium per metered spray.

    One drop of cromolyn sodium ophthalmic solution contains approximately 1.6 mg of cromolyn sodium.

    Pediatric Patients

    Allergic Rhinitis Intranasal

    Children ≥2 years of age: 1 spray (5.2 mg) in each nostril 3 or 4 times daily given at regular intervals (morning, noon, dinner, bedtime) for ≤12 weeks. When necessary, may be used up to 6 times daily.

    Allergic Ocular Disorders Ophthalmic

    Children ≥4 years of age: 1 or 2 drops in each eye 4–6 times daily at regular intervals.

    Do not exceed recommended frequency of administration.

    Adults

    Allergic Rhinitis Intranasal

    1 spray (5.2 mg) in each nostril 3 or 4 times daily (morning, noon, dinner, bedtime) for ≤12 weeks. When necessary, may be used up to 6 times daily.

    Allergic Ocular Disorders Ophthalmic

    1 or 2 drops in each eye 4–6 times daily at regular intervals.

    Warnings

    Contraindications

  • Known hypersensitivity to cromolyn sodium or any ingredient in the formulations.

    • Warnings/Precautions

    Warnings

    General Precautions

    Ocular Effects

    Ophthalmic solution: Transient stinging or burning sensation may occur.

    Respiratory Effects

    Nasal solution: Transient nasal stinging and/or sneezing may occur immediately. Discontinue drug if nasal irritation occurs.

    Specific Populations

    Pregnancy

    Category B.

    Lactation

    Not known whether cromolyn is distributed into milk. Use ophthalmic solution with caution. With nasal spray, consult a clinician prior to use.

    Pediatric Use

    Safety and efficacy of cromolyn sodium given as the nasal solution or ophthalmic solution not established in children <2 or <4 years of age, respectively.

    Geriatric Use

    Ophthalmic solution: No differences in safety or efficacy relative to younger adults.

    Common Adverse Effects

    Nasal solution: Nasal burning and stinging, nasal irritation, sneezing.

    Ophthalmic solution: Transient ocular stinging or burning upon instillation.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords

    AI Assitant